The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study

被引：0

作者：

Corren, J. ^{[1
]}

Colice, G. ^{[2
]}

Salapa, K. ^{[3
]}

Bowen, K. ^{[4
]}

Llanos-Ackert, J. ^{[5
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[2] AstraZeneca, San Francisco, CA USA

[3] AstraZeneca, Warsaw, Poland

[4] AstraZeneca, Gaithersburg, MD USA

[5] Amgen Inc, Gaithersburg, MD USA

来源：

ALLERGY | 2020年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

1105

引用

页码：19 / 19

页数：1

共 50 条

[21] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study [J].

Hoyte, Flavia ;

Martin, Neil ;

Kmita, Kamil ;

Roseti, Stephanie ;

Llanos-Ackert, Jean-Pierre ;

Lindsley, Andrew ;

Colice, Gene .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) :AB63-AB63

[22] Effect of Tezepelumab on Exercise Tolerance in Patients With Severe, Uncontrolled Asthma From the NAVIGATOR Study [J].

Lugogo, N. L. ;

Kraft, M. ;

Corren, J. ;

Martin, N. ;

Shenoy, K. V. ;

Shenoy, S. F. ;

Chandarana, S. ;

Ambrose, C. S. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209

[23] The Impact of Tezepelumab on Hospitalization and Emergency Department Visits in Patients with Severe Uncontrolled Asthma: Results from the Pathway Phase 2b Trial [J].

Corren, J. ;

Chen, S. ;

Callan, L. ;

Garcia Gil, E. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199

[24] Effect Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Age Of Onset, Allergic Status, And Eosinophilic Phenotype [J].

Mathur, Sameer ;

Hill, Jennifer ;

Ambrose, Chris ;

Martin, Nicole ;

Llanos-Ackert, Jean-Pierre ;

Martin, Neil ;

Colice, Gene .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) :AB17-AB17

[25] Effect of tezepelumab in patients with severe, uncontrolled asthma by age of onset, allergic status, and eosinophilic phenotype [J].

Mathur, S. K. ;

Hill, J. L. ;

Ambrose, C. S. ;

Martin, N. ;

Llanos, J-P ;

Martin, N. ;

Colice, G. .

THORAX, 2023, 78 (SUPPL_4) :A86-A86

[26] Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study [J].

Ambrose, C. S. ;

Cook, B. ;

Roseti, S. L. ;

Gelhorn, H. ;

Cutts, K. ;

Lindsley, A. W. ;

Colice, G. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205

[27] Oral Corticosteroid-Sparing Effect of Tezepelumab in Adults With Severe Asthma: Results From the DESTINATION Study [J].

Menzies-Gow, A. ;

Wechsler, M. E. ;

Brightling, C. E. ;

Korn, S. ;

Israel, E. ;

Bednarczyk, A. ;

Ponnarambil, S. ;

Caveney, S. ;

Almqvist, G. ;

Cook, B. ;

Martin, N. ;

Kotalik, A. ;

Colice, G. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207

[28] The Effect of Tezepelumab on Exacerbations in Patients with Severe, Uncontrolled Asthma According to Baseline Serum IL-5 and IL-13 Levels: Results from the Phase 2b PATHWAY Study [J].

Corren, J. ;

Ambrose, C. ;

Salapa, K. ;

Parnes, J. R. ;

Pham, T. ;

Griffiths, J. M. ;

Colice, G. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201

[29] Tezepelumab Treatment Effect on Annualized Rate of Exacerbations by Baseline Biomarkers in Uncontrolled Severe Asthma Patients: Phase 2b PATHWAY Study [J].

Corren, J. ;

Garcia Gil, E. ;

Parnes, J. R. ;

Pham, T. ;

Griffiths, J. M. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199

[30] Effect of omalizumab on asthma control, exacerbation rate and quality of life in Italian patients with severe allergic asthma: results from the longitudinal phase of the proxima study [J].

Caruso, C. ;

Rottoli, P. ;

Bucca, C. ;

Zappa, M. C. ;

Berlendis, M. A. ;

Michetti, G. ;

Macciocchi, B. ;

Bartezaghi, M. ;

Rigoni, L. ;

Canonica, G. W. .

ALLERGY, 2017, 72 :415-416

← 1 2 3 4 5 →